Herbert A. Fritsche, Ph.D.

Principal Investigator and Chief Science Officer

Dr. Fritsche is a world renowned Clinical Chemist and was Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, M.D. Anderson Cancer Center in Houston, Texas. During his 41 years at M.D. Anderson Cancer Center, Dr. Fritsche focused his research activities on the development and validation of cancer diagnostics. Dr. Fritsche has participated in the validation and FDA clearance process for every commercial serum tumor marker product currently in use in the United States. Dr. Fritsche has served as President of the Clinical Ligand Assay Society (CLAS) and on many various national committees for both the CLAS and the American Association for Clinical Chemistry (AACC). He is a Fellow of the National Academy of Clinical Biochemistry and was awarded the National Award for Contributions in Education by the AACC; the Outstanding Clinical Chemist Award by the Texas Section, AACC; a Dean's Excellence Award from the University of Texas Graduate School of Biomedical Science; a Distinguished Scientist Award from the CLAS; the Johnson and Johnson Award for Outstanding Research and Contributions to Clinical Biochemistry from the National Academy of Clinical Biochemistry; the Morton K Schwartz Award for Outstanding Achievements in the field of Cancer Diagnostics from AACC, the Carl Jolliff Award for Lifetime Achievements in Immunology and Immunodiagnostics from the Immunology Division of the AACC, the Morton K Schwartz Award for significant contributions to the development of cancer diagnostics from the New York Metro Division of the AACC and most recently, the 2015 Abbott Award, awarded in Poland, by the International Society of Oncology and Biomarkers (ISOBM) for outstanding contributions to the field of basic and clinical oncology. Dr. Fritsche served on the Expert Panel for developing Tumor Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement, and currently serves on the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry. In addition, he serves on the Editorial Board of six international scientific journals. Dr. Fritsche serves as a consultant/advisor to the US National Cancer Institute and for some major international diagnostic companies and biotech start-up companies. Dr. Fritsche has published over 200 peer reviewed scientific papers, invited articles and book chapters. Dr. Fritsche holds 3 patents. He has lectured extensively for many years at international and national meetings of medical and professional societies and he is recognized internationally as an expert in the field of clinical chemistry, cancer diagnostics and laboratory medicine.

Team members

Stephen D. Barnhill, M.D.

Dr. Stephen D. Barnhill is a physician Fellowship trained in…

Anthony J. Hall, M.D.

Dr. Anthony Hall is a Neurosurgeon, Board Certified by the American…

Margaret Dingle Spence

Dr. Spence is a Consultant in Oncology & Palliative Medicine at the…

Herbert A. Fritsche, Ph.D.

Dr. Fritsche is a world renowned Clinical Chemist and was Professor of…

Rama Madyastha, M.D., Ph.D

Dr. Madyastha is a Board Certified Clinical Laboratory Scientist and…

Isabelle Guyon, Ph.D.

Dr. Guyon is co-inventor of the support vector machine (SVM)…

Priest Douglas Smith

Priest Douggie, a Jamaican, was born in Kinston, Jamaica and began…